增强了计数数据分析的建模方法,重点关注物质使用结果
Niloufar Dousti Mousavi1, Jie Yang2, Robin Mermelstein3
1Department of Public Health Sciences, University of Chicago, Chicago, IL, USA. niloufar.dousti@gmail.com.
Journal of behavioral medicine
|December 1, 2025
概括
这项研究表明,零膨胀β-二项式 (ZIBB) 和β-二项式障碍 (BBH) 模型比传统的零膨胀Poisson (ZIP) 和零膨胀负二项式 (ZINB) 模型更好地分析青少年吸烟计数数据. ZIBB模型有效地捕捉了U形数据分布.
科学领域:
- 行为医学是一种行为医学.
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 准确的统计建模对于行为医学中计数数据分析至关重要.
- 传统的波桑和负二项式模型与多余的零和U形分布作斗争.
- 零膨胀和障碍模型为零重数据提供了替代方案.
研究的目的:
- 对青少年物质使用计数数据的零膨胀Poisson (ZIP) 和零膨胀负二项式 (ZINB) 模型的局限性进行批判性检查.
- 评估更广泛的统计模型,包括零膨胀β-二项式 (ZIBB) 和β-二项式障碍 (BBH) 模型.
- 识别用于分析具有复杂分布的稀疏计数数据的优质模型,例如U形模式.
主要方法:
- 对青少年吸烟行为的分析 (
- 过去一个月吸烟的日数") 来自一项纵向研究 (N=1263) 跨越八个波.
- 通过Kolmogorov-Smirnov (KS) 测试和通过确认研究进行验证来识别模型.
- 在各种模型中以Akaike信息标准 (AIC) 为指导的回归分析:ZIP,PH,ZINB,NBH,ZINB-r,NBH-r,ZIBB,BBH,ZIBB-n,BBH-n,ZIBB-ab,BBH-ab,ZIBNB和BNBH.
主要成果:
- 零膨胀β-二项式 (ZIBB) 和β-二项式障碍 (BBH) 模型显示出卓越的模型拟合和回归分析能力.
- ZIBB模型有效地捕获了青少年吸烟频率中观察到的U形分布.
- 这些发现凸显了复杂计数数据中常用的ZIP和ZINB模型的局限性.
结论:
- ZIBB和BBH模型为行为医学研究中的计数数据提供了更准确,更可靠的分析,特别是在过多的零和U形分布的情况下.
- 除了ZIP和ZINB之外,探索更广泛的统计模型对于提高研究准确性至关重要.
- 这项研究倡导采用像ZIBB这样的先进模型来增强青少年物质使用和其他行为数据的解释.
更多相关视频
相关概念视频
Substance Use Disorders Affecting Sleep
369
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
369
Mechanistic Models: Compartment Models in Individual and Population Analysis
226
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
226
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
463
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
463
Model Approaches for Pharmacokinetic Data: Compartment Models
504
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
504
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Analysis of Population Pharmacokinetic Data
657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657


